Management sequence for moderate to severe cyclical mastalgia affecting quality of life.

Cyclical mastalgia most common type of breast pain, accounting for 40 percent of all cases referred to breast clinic. there important correlation with the menstrual cycle with this type of mastalgia. the aim of study to detect cyclical mastalgia respond to reassurance with recommendations or respond to medical treatment on the one hand and study effectiveness and side effects of medical treatment of cyclical mastalgia on the other hand. the study including 147 female patients with cyclical mastalgia affecting quality of life attending Afak hospital and private clinic between August 2014 _ August 2021 Data recorded on database, history, clinical examination and investigated by radio - image (mammography or ultrasound) then managed at first with reassurance with recommendations and if patients not respond to reassurance then treated with either evening primrose oil or Cabergoline drug as result (40 %) of patient respond to reassurance with recommendations the remainder (60 %) divided into two groups, one group treated with evening primrose oil the response for such drug was (66 %) and side effect of same drug develop in (4 %) of patients. While another group treated with Cabergoline, the response to this drug was (88%) and side effect develop in (89 %) of patients. conclusion, cyclical mastalgia common condition affecting quality of life needs carefull assessment to avoid missed breast carcinoma and may require medical treatment. [ABSTRACT FROM AUTHOR]